Cisapride Tablets and Insulin Glargine (U-100) Vials
Determining the interaction of Cisapride Tablets and Insulin Glargine (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cisapride
Brand name: Propulsid
Synonyms: n.a.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cisapride Tablets-Insulin Glargine (U-300) Pens
- Cisapride Tablets-Insulin glargine and lixisenatide
- Cisapride Tablets-Insulin glargine and lixisenatide Subcutaneous
- Cisapride Tablets-Insulin glargine, recombinant Subcutaneous
- Cisapride Tablets-Insulin glulisine
- Cisapride Tablets-Insulin Glulisine (Cartridges and Pens)
- Insulin Glargine (U-100) Vials-Cisatracurium
- Insulin Glargine (U-100) Vials-Cisatracurium Besylate
- Insulin Glargine (U-100) Vials-Cisatracurium Besylate Injection
- Insulin Glargine (U-100) Vials-Cisatracurium besylate Intravenous
- Insulin Glargine (U-100) Vials-Cisplatin
- Insulin Glargine (U-100) Vials-Cisplatin Intravenous